By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “ACAROID” by Jonas KAlle, representing Merck KGaA. This application was made available to the public on July 01, 2014 (see also Trademarks).
The serial number for this application is 79147730.
The international trademark goods and services class code for this trademark application is 005.
As submitted by the applicant, this trademark application relates to the following goods and services: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use.
The owner/registrar information for this application is: Jonas KAlle, Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt, FED REP GERMANY.
Keywords for this news article include: Merck KGaA, Trademarks.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Merck KGaA’s Trademark Application for “ACAROID” Filed
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
The Fed model compares the return profile of stocks and US government bonds.
Why distillate crack spreads will likely experience more volatility.
When people talk about interest rates, real estate prices, and cyclical and secular trends, there’s one piece of context they tend not to mention.
The saying that there is no such thing as a free lunch is very much true for Robinhood.
Another Black Swan event is taking place right now. And it’s likely to have a similar effect on uranium prices.
A weekly five-point roundup of critical events in fintech, the future of finance and the next wave of banking industry transformation.
